Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1996 Mar;117(6):995–999. doi: 10.1111/j.1476-5381.1996.tb16688.x

Necessity of dual blockade of endothelin ETA and ETB receptor subtypes for antagonism of endothelin-1-induced contraction in human bronchi.

T Fukuroda 1, S Ozaki 1, M Ihara 1, K Ishikawa 1, M Yano 1, T Miyauchi 1, S Ishikawa 1, M Onizuka 1, K Goto 1, M Nishikibe 1
PMCID: PMC1909802  PMID: 8882588

Abstract

1. Endothelin (ET)-1 has been postulated to be involved in the development of obstructive airway diseases in man. In the present study, we attempted to characterize ET receptor subtypes mediating ET-1-induced contraction in human isolated bronchi. The ET receptor antagonists used in the present study were BQ-123 (ETA receptor-selective), BQ-788 (ETB receptor-selective) and BQ-928 (ETA/ETB dual). Sarafotoxin S6c (S6c) was also used as an ETB receptor-selective agonist. 2. In human bronchi, ET-1 and S6c (10(-12)M to 10(-7) M) produced concentration-dependent contraction with almost equal potency (pD2: 8.88 +/- 0.16 for ET-1 and 9.42 +/- 0.15 for S6c). The contraction induced by S6c was competitively antagonized by BQ-788 alone (1 and 10 microM) with a pKB value of 7.49 +/- 0.21, suggesting that the stimulation of ETB receptors causes a contraction of human bronchi. However, contrary to expectation, the concentration-response curves for ET-1 were not affected by BQ-788. The ET-1- and S6c-induced contractions were not affected by BQ-123 (10 microM). Thus, ET-1-induced contraction of human bronchi is not antagonized by BQ-123 alone or by BQ-788 alone. 3. Combined treatment with 10 microM BQ-123 and 10 microM BQ-788 significantly antagonized the contraction induced by ET-1 with a dose-ratio of 11. BQ-928 also significantly antagonized ET-1-induced contraction with a pKB value of 6.32 +/- 0.24. 4. The specific binding of [125I]-ET-1 to human bronchial membrane preparations was inhibited by BQ-123 (100 pM to 1 microM) by approximately 40%. Combination treatment with BQ-788 (100 pM to 1 microM) completely inhibited the BQ-123-resistant component of [125I]-ET-1 specific binding. 5. In conclusion, the present study demonstrates that BQ-788 alone cannot inhibit ET-1-induced contractions in human bronchi, although human bronchial ETB receptors are BQ-788-sensitive. Furthermore, it was shown that blockade of both receptor subtypes antagonizes ET-1-induced contraction, and that both receptor subtypes co-exist in human bronchial smooth muscles. These findings suggest that ETA receptors as well as ETB receptors are involved in ET-1-induced contraction in human bronchi. If ET-1 is involved in human airway diseases, dual blockade of ETA and ETB receptors may be necessary to treat the diseases.

Full text

PDF
995

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Advenier C., Sarria B., Naline E., Puybasset L., Lagente V. Contractile activity of three endothelins (ET-1, ET-2 and ET-3) on the human isolated bronchus. Br J Pharmacol. 1990 May;100(1):168–172. doi: 10.1111/j.1476-5381.1990.tb12071.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Arai H., Hori S., Aramori I., Ohkubo H., Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature. 1990 Dec 20;348(6303):730–732. doi: 10.1038/348730a0. [DOI] [PubMed] [Google Scholar]
  3. Barnes P. J. Endothelins and pulmonary diseases. J Appl Physiol (1985) 1994 Sep;77(3):1051–1059. doi: 10.1152/jappl.1994.77.3.1051. [DOI] [PubMed] [Google Scholar]
  4. Battistini B., Warner T. D., Fournier A., Vane J. R. Characterization of ETB receptors mediating contractions induced by endothelin-1 or IRL 1620 in guinea-pig isolated airways: effects of BQ-123, FR139317 or PD 145065. Br J Pharmacol. 1994 Apr;111(4):1009–1016. doi: 10.1111/j.1476-5381.1994.tb14844.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Carpi S., Marini M., Vittori E., Vassalli G., Mattoli S. Bronchoconstrictive responses to inhaled ultrasonically nebulized distilled water and airway inflammation in asthma. Chest. 1993 Nov;104(5):1346–1351. doi: 10.1378/chest.104.5.1346. [DOI] [PubMed] [Google Scholar]
  6. Fukuroda T., Kobayashi M., Ozaki S., Yano M., Miyauchi T., Onizuka M., Sugishita Y., Goto K., Nishikibe M. Endothelin receptor subtypes in human versus rabbit pulmonary arteries. J Appl Physiol (1985) 1994 May;76(5):1976–1982. doi: 10.1152/jappl.1994.76.5.1976. [DOI] [PubMed] [Google Scholar]
  7. Fukuroda T., Ozaki S., Ihara M., Ishikawa K., Yano M., Nishikibe M. Synergistic inhibition by BQ-123 and BQ-788 of endothelin-1-induced contractions of the rabbit pulmonary artery. Br J Pharmacol. 1994 Oct;113(2):336–338. doi: 10.1111/j.1476-5381.1994.tb16901.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hay D. W., Luttmann M. A., Hubbard W. C., Undem B. J. Endothelin receptor subtypes in human and guinea-pig pulmonary tissues. Br J Pharmacol. 1993 Nov;110(3):1175–1183. doi: 10.1111/j.1476-5381.1993.tb13938.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Henry P. J. Endothelin-1 (ET-1)-induced contraction in rat isolated trachea: involvement of ETA and ETB receptors and multiple signal transduction systems. Br J Pharmacol. 1993 Sep;110(1):435–441. doi: 10.1111/j.1476-5381.1993.tb13829.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Henry P. J., Goldie R. G. ETB but not ETA receptor-mediated contractions to endothelin-1 attenuated by respiratory tract viral infection in mouse airways. Br J Pharmacol. 1994 Aug;112(4):1188–1194. doi: 10.1111/j.1476-5381.1994.tb13209.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Henry P. J., Rigby P. J., Self G. J., Preuss J. M., Goldie R. G. Relationship between endothelin-1 binding site densities and constrictor activities in human and animal airway smooth muscle. Br J Pharmacol. 1990 Aug;100(4):786–792. doi: 10.1111/j.1476-5381.1990.tb14093.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Ihara M., Noguchi K., Saeki T., Fukuroda T., Tsuchida S., Kimura S., Fukami T., Ishikawa K., Nishikibe M., Yano M. Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor. Life Sci. 1992;50(4):247–255. doi: 10.1016/0024-3205(92)90331-i. [DOI] [PubMed] [Google Scholar]
  13. Ishikawa K., Ihara M., Noguchi K., Mase T., Mino N., Saeki T., Fukuroda T., Fukami T., Ozaki S., Nagase T. Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc Natl Acad Sci U S A. 1994 May 24;91(11):4892–4896. doi: 10.1073/pnas.91.11.4892. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Knott P. G., D'Aprile A. C., Henry P. J., Hay D. W., Goldie R. G. Receptors for endothelin-1 in asthmatic human peripheral lung. Br J Pharmacol. 1995 Jan;114(1):1–3. doi: 10.1111/j.1476-5381.1995.tb14895.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Masaki T. Tissue specificity of the endothelin-induced responses. J Cardiovasc Pharmacol. 1991;17 (Suppl 7):S1–S4. doi: 10.1097/00005344-199100177-00002. [DOI] [PubMed] [Google Scholar]
  16. Nomura A., Uchida Y., Kameyana M., Saotome M., Oki K., Hasegawa S. Endothelin and bronchial asthma. Lancet. 1989 Sep 23;2(8665):747–748. doi: 10.1016/s0140-6736(89)90814-3. [DOI] [PubMed] [Google Scholar]
  17. Noveral J. P., Rosenberg S. M., Anbar R. A., Pawlowski N. A., Grunstein M. M. Role of endothelin-1 in regulating proliferation of cultured rabbit airway smooth muscle cells. Am J Physiol. 1992 Sep;263(3 Pt 1):L317–L324. doi: 10.1152/ajplung.1992.263.3.L317. [DOI] [PubMed] [Google Scholar]
  18. Sakurai T., Yanagisawa M., Takuwa Y., Miyazaki H., Kimura S., Goto K., Masaki T. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature. 1990 Dec 20;348(6303):732–735. doi: 10.1038/348732a0. [DOI] [PubMed] [Google Scholar]
  19. Springall D. R., Howarth P. H., Counihan H., Djukanovic R., Holgate S. T., Polak J. M. Endothelin immunoreactivity of airway epithelium in asthmatic patients. Lancet. 1991 Mar 23;337(8743):697–701. doi: 10.1016/0140-6736(91)90279-x. [DOI] [PubMed] [Google Scholar]
  20. Warner T. D., Allcock G. H., Corder R., Vane J. R. Use of the endothelin antagonists BQ-123 and PD 142893 to reveal three endothelin receptors mediating smooth muscle contraction and the release of EDRF. Br J Pharmacol. 1993 Oct;110(2):777–782. doi: 10.1111/j.1476-5381.1993.tb13879.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Williams D. L., Jr, Jones K. L., Pettibone D. J., Lis E. V., Clineschmidt B. V. Sarafotoxin S6c: an agonist which distinguishes between endothelin receptor subtypes. Biochem Biophys Res Commun. 1991 Mar 15;175(2):556–561. doi: 10.1016/0006-291x(91)91601-8. [DOI] [PubMed] [Google Scholar]
  22. Yoneyama T., Hori M., Makatani M., Yamamura T., Tanaka T., Matsuda Y., Karaki H. Subtypes of endothelin ETA and ETB receptors mediating tracheal smooth muscle contraction. Biochem Biophys Res Commun. 1995 Feb 15;207(2):668–674. doi: 10.1006/bbrc.1995.1239. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES